Abstract
Fat grafting in the surgical treatment of breast cancer has become popular in a short period of time because of the rising expectations of good esthetic results by the patients as well as the simplicity of the technique; however, the oncological safety for breast cancer patients remains a matter of debate. The procedure raises many questions considering that recent in-vitro studies have shown that fat grafting could promote tumor recurrence through diverse mechanisms, or even facilitate distant metastasis. We present a review of the currently available experimental and clinical data in order to describe and discuss patient selection criteria following breast cancer surgery.
Original language | English |
---|---|
Pages (from-to) | 1088-1102 |
Number of pages | 15 |
Journal | European Journal of Surgical Oncology |
Volume | 42 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2016 |
Keywords
- ASCs (adipose stem cells)
- Breast cancer
- Fat grafting
- Lipoffiling
- Oncological outcome
- Safety
ASJC Scopus subject areas
- Oncology
- Surgery